About Hypotonia-speech impairment-severe cognitive delay syndrome due to NALCN deficiency
Hypotonia-speech impairment-severe cognitive delay syndrome due to NALCN deficiency is a rare disease catalogued by Orphanet (ORPHA:700336). It is associated with the NALCN gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Hypotonia-speech impairment-severe cognitive delay syndrome due to NALCN deficiency trials.
Search ClinicalTrials.gov for "Hypotonia-speech impairment-severe cognitive delay syndrome due to NALCN deficiency" or filter by Orphanet code ORPHA:700336 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Hypotonia-speech impairment-severe cognitive delay syndrome due to NALCN deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Hypotonia-speech impairment-severe cognitive delay syndrome due to NALCN deficiency. Updated daily.